While short-term studies have not raisedmajor safety signals, animal studies and secondary analyses of clinical trialshave raised concerns regarding a potential association with acute pancreatitis,C-cell hyperplasia, and medullary thyroid carcinoma—risks that are alsorecognized with conventional GLP-1 RAs [76, 77]. This evidence concerns the gene GLP1R and C-cell hyperplasia.